Tobacco smoking--clinical and social issues.
Explore the source record for details and available documents.
Humans↗
Biomedical subjects
K L Sees
Publications and source records attributed to K L Sees.
Combining clonidine and nicotine replacement for treatment of nicotine withdrawal.
The U.S. Surgeon General's 1988 report on nicotine addiction has increased the need for the substance abuse treatment community to become more involved in smoking cessation programs. A unique approach to nicotine detoxification has been developed at the Haight Ashbury Free Clinics' Drug Detoxification, Rehabilitation and Aftercare Project. After an evaluation by a physician, a thorough explanation of the treatment plan, and if the patient is interested, a combination of clonidine via the transdermal patch (Catapres-TTS) and of nicotine replacement via nicotine polacrilex (Nicorette) is used. By combining a Nicorette taper with clonidine, the physician can control the rate of nicotine withdrawal (Nicorette) and the extent to which withdrawal symptoms are treated (clonidine). This appears to be an effective, comfortable method for detoxification from cigarettes and nicotine. Its use should prove helpful as an adjunct to a comprehensive smoking cessation program.
Clonidine↗
The smoke-free workplace.
As the significance of drug use and/or abuse in the workplace is explored, and the public is encouraged to embrace the War on Drugs, policymakers and treatment personnel must not concentrate only on illicit drugs but on licit drugs as well. This article explores the impact of cigarette smoking in the workplace and reviews alternatives for decreasing or eliminating exposure to involuntary smoke in the workplace.
Environment↗
Pharmacological adjuncts for the treatment of withdrawal syndromes.
Alternative explanations for symptoms that occur during the period of drug (medical or nonmedical) withdrawal are examined. These symptoms are not necessarily due to the discontinuation of the drug and should be considered when treating a patient for a withdrawal syndrome. The rationale behind treating withdrawal syndromes and criteria to consider for hospitalizing a patient during the withdrawal period are discussed. The main focus of this article is the appropriate use of prescription drugs for treating withdrawal syndromes. In addition, protocols of the Drug Detoxification, Rehabilitation, and Aftercare Project of the Haight Ashbury Free Clinics are reviewed in detail. Finally, information is provided on some potentially promising medications that are currently being investigated for the treatment of withdrawal.
Humans↗